Description
CEFURONET CV 375 Tablets are oral antibiotics combining Cefuroxime 250 mg and Clavulanic Acid 125 mg per tablet. This combination enhances the efficacy of Cefuroxime by inhibiting beta-lactamase enzymes produced by resistant bacteria, thereby broadening its spectrum of activity.
Indications:
CEFURONET CV 375 is indicated for the treatment of various bacterial infections, including:
-
Respiratory tract infections (e.g., pharyngitis, tonsillitis, sinusitis, pneumonia)
-
Urinary tract infections
-
Skin and soft tissue infections
-
Otitis media
-
Gonorrhea
-
Lyme disease
Dosage and Administration:
The dosage regimen should be determined by a healthcare professional based on the patient’s condition and severity of the infection. It is typically administered orally, with or without food.
Contraindications:
-
Known hypersensitivity to Cefuroxime, Clavulanic Acid, or any component of the formulation
-
History of severe allergic reactions to cephalosporins or penicillins
Precautions:
-
Use with caution in patients with a history of gastrointestinal disease, particularly colitis
-
Monitor renal function in patients with renal impairment
-
Not recommended for use in neonates due to the presence of benzyl alcohol as a preservative
Side Effects:
Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Allergic reactions, including rash and anaphylaxis, may occur. If any severe side effects are observed, discontinue use and consult a healthcare professional immediately.
Storage:
Store at room temperature, away from moisture and heat. Keep out of reach of children.
Reviews
There are no reviews yet.